Cyproheptadine Hydrochloride
Product Images NDC 10135-638

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 10135-638). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Of The Anhydrous Salt (Cyproheptadine Hydrochloride 01)

FDA Label Image

Label1

Label1
Each tablet of KLRIGRER contains Cyproheptadine HCY, USP at the concentration of 4mg. The package insert should be referred to for full prescribing information, including usual dosage indications. These tablets should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) and must be kept out of children's reach. The medication is distributed by Marlex Pharmaceuticals, Inc. in New Castle, DE 19720. This product has 100 tablets and is available only through prescription.*
FDA Label Image

Label2

Label2
This is a medication bottle containing Cyproheptadine HCI, USP with each tablet containing 4mg. Normal dosage and other important information can be found in the package insert. It is instructed to store at room temperature between 20-25°C (68-77°F). The container should be kept closed and out of reach of children. This medication is prescription-only and distributed by Marlex Pharmaceuticals Inc. from their New Castle, DE location. The bottle contains 1000 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.